Nutrien earnings up next: Can potash offset nitrogen weakness?

Nutrien Ltd (NTR) raised its full-year retail adjusted EBITDA guidance to $1.72-$1.85B, citing record potash volumes. Challenges include elevated sulfur costs, Brazil retail wind-down, and White Springs phosphate facility shutdown. CEO Ken Seitz discussed long-term phosphate strategy, potash automation, and market flexibility. CFO Mark Thompson outlined retail EBITDA growth and capital allocation priorities.

The 2018 U.S. Farm Bill expired on Oct. 1, with Congress failing to pass a new one. The bill, designed for a different farm economy, included unchanged reference prices for crops, which have not kept pace with rising production costs. Farmers now face higher input costs, increased debt, and lower profits, with government aid playing a larger role. The Justice Department and FTC are investigating potential price coordination among fertilizer companies.

Nutrien (NTR) reported Q3 2026 earnings, highlighting higher operating cash flows, $1.3B returned to shareholders, and portfolio optimization. They plan to shut down the White Springs facility in Q2 2027, expecting improved EBITDA and free cash flow. Q3 results include $1.31B adjusted EBITDA, with potash and nitrogen segments performing strongly. Full-year guidance was updated, reflecting strong market fundamentals and strategic decisions.

Nutrien Ltd. (NTR-T) will not sell its phosphate division, citing market challenges due to the Middle East war and volatile sulphur prices. The division reported a $50M loss in Q3, contributing to a 39% drop in overall net earnings. Nutrien will instead shut down its White Springs facility in 2027, expecting $50M annual cost savings.

Nutrien Ltd. reported a 39% decrease in Q3 net earnings to $288M, missing estimates. Phosphate and nitrogen divisions underperformed, with costs rising due to facility shutdowns and higher input prices. Potash sales guidance was increased to 14.8M tonnes. According to the company, the Florida phosphate facility will close in Q2 2027.

Nutrien Ltd. (NTR) reported Q3 earnings of $284M, or 60 cents per share, missing analysts' estimates of 74 cents. Adjusted earnings were 61 cents per share. Revenue was $6.06B, exceeding expectations of $5.86B, according to Zacks.